High Dose Cyclophosphamide for Treatment of Scleroderma
NCT00501995 is a phase 3 interventional trial sponsored by Johns Hopkins University. As of 18 Nov 2026, it is completed. It studies Cyclophosphamide in Scleroderma. The registry lists an enrollment of 6 participants. The registry lists a start date of 28 Feb 2001 and a primary completion date of 31 Jul 2008.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00501995 |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | Johns Hopkins University |
| Enrollment | 6 |
| Conditions | Scleroderma |
| Drugs | Cyclophosphamide |
| Start | 28 Feb 2001 |
| Primary completion | 31 Jul 2008 |
| Study completion | 31 May 2010 |
| Last update posted | 14 Jun 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Fredrick M Wigley, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00501995
Each answer restates registry values shown on this page.
What is NCT00501995?
NCT00501995 is a phase 3 interventional trial sponsored by Johns Hopkins University. It studies Cyclophosphamide in Scleroderma.
Who leads NCT00501995?
The registry names Fredrick M Wigley, MD (principal investigator, Johns Hopkins University) as the overall official.
Which drugs does NCT00501995 study?
The registered drug and biological interventions are Cyclophosphamide.
When did NCT00501995 end?
The registry lists a primary completion date of 31 Jul 2008 and a study completion date of 31 May 2010. The sponsor last updated the record on 14 Jun 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.